Ventricular Tachycardia Cohort

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

NOT_YET_RECRUITING

Total Enrollment

1500 participants

Study Classification

OBSERVATIONAL

Study Start Date

2025-09-01

Study Completion Date

2029-12-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The goal of this observational study is to detect the long-term risk of a composite endpoint event in adult patients with ventricular tachycardia (VT) who are managed with catheter ablation or non-ablation management (including modern drug therapy and/or ICD therapy).

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Catheter Ablation for Nonsustained Ventricular Tachycardia in Patients With Ischemic Cardiomyopathy

NCT03147027

Ventricular Tachycardia Ischemic Cardiomyopathy Reduced LVEF

UNKNOWN

Computational Cardiac Imaging Analysis to Guide Ventricular Tachycardia Ablation Procedures (AI-VT)

NCT06964152

Ventricular Tachycardia (VT) Premature Ventricular Contraction (PVC) Ventricular Fibrillation

ENROLLING_BY_INVITATION NA

Catheter Ablation of Haemodynamically Not-tolerated Electrical Storm in Structural Heart Disease

NCT06455020

Ventricular Tachycardia

NOT_YET_RECRUITING NA

Anti-arrhythmic Medication v. MRI-Merge Ablation in the Treatment of Ventricular Tachycardia

NCT00721032

Ventricular Tachycardia

WITHDRAWN NA

Computed Tomography-Guided Catheter Ablation for Ventricular Tachycardia

NCT05225935

Ventricular Tachycardia

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Ventricular Tachycardia (VT)

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Normal treatment

Treatment without intervention of catheter ablation or Implantable cardioverter defibrillator.

Intervention

Intervention Type DEVICE

Treatment with intervention of catheter ablation or Implantable cardioverter defibrillator.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Intervention

Treatment with intervention of catheter ablation or Implantable cardioverter defibrillator.

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Sustained ventricular tachycardia (VT), defined as VT lasting ≥30 seconds or requiring intervention due to hemodynamic compromise within 30 seconds; or Clinically significant non-sustained VT (NSVT) where the treating clinician has determined that therapeutic intervention is necessary.

Exclusion Criteria

* Concurrent participation in any interventional clinical trial that, in the judgment of the investigator, could interfere with the data collection or outcome assessment of this observational study.

Eligible Sex

ALL

Accepts Healthy Volunteers

No